13D/13G Filings - VIKING GLOBAL INVESTORS LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...3, 4, 5, 6, 7, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
5:02 pm
Unchanged
2021-12-31 13G Adaptive Biotechnologies Corporation
ADPT
VIKING GLOBAL INVESTORS LP 29,993,708
21.300%
0
(Unchanged)
Filing
History
2022-02-14
5:02 pm
Sale
2021-12-31 13G Athira Pharma, Inc.
ATHA
VIKING GLOBAL INVESTORS LP 0
0.000%
-2,120,653decrease
(Position Closed)
Filing
History
2022-02-14
5:02 pm
Unchanged
2021-12-31 13G Inhibrx Biosciences, Inc.
INBX
VIKING GLOBAL INVESTORS LP 5,305,866
14.000%
0
(Unchanged)
Filing
History
2022-02-14
5:02 pm
Sale
2021-12-31 13G Edgewise Therapeutics, Inc.
EWTX
VIKING GLOBAL INVESTORS LP 2,727,249
5.500%
-625,032decrease
(-18.64%)
Filing
History
2022-02-14
5:02 pm
Sale
2021-12-31 13G Mudrick Capital Acquisition Corporation II
MUDS
VIKING GLOBAL INVESTORS LP 0
0.000%
-3,047,904decrease
(Position Closed)
Filing
History
2022-02-14
5:01 pm
Purchase
2021-12-31 13G Pharvaris N.V.
PHVS
VIKING GLOBAL INVESTORS LP 2,455,536
7.400%
35,381increase
(+1.46%)
Filing
History
2022-02-14
5:01 pm
Sale
2021-12-31 13G PMV Pharmaceuticals, Inc.
PMVP
VIKING GLOBAL INVESTORS LP 1,790,284
3.900%
-573,778decrease
(-24.27%)
Filing
History
2022-02-14
5:01 pm
Unchanged
2021-12-31 13G PROCEPT BioRobotics Corporation
PRCT
VIKING GLOBAL INVESTORS LP 4,907,892
11.300%
0
(Unchanged)
Filing
History
2022-02-14
5:01 pm
Unchanged
2021-12-31 13G Rallybio Corporation
RLYB
VIKING GLOBAL INVESTORS LP 4,194,777
13.100%
0
(Unchanged)
Filing
History
2022-02-14
5:01 pm
Purchase
2021-12-31 13G Roivant Sciences Ltd.
ROIV
VIKING GLOBAL INVESTORS LP 88,238,700
12.800%
88,238,700increase
(New Position)
Filing
History
2022-02-14
5:01 pm
Sale
2021-12-31 13G Zentalis Pharmaceuticals, Inc.
ZNTL
VIKING GLOBAL INVESTORS LP 2,118,284
4.700%
-893,000decrease
(-29.66%)
Filing
History
2022-02-14
5:01 pm
Unchanged
2021-12-31 13G Talaris Therapeutics, Inc.
TALS
VIKING GLOBAL INVESTORS LP 328,962
8.000%
0
(Unchanged)
Filing
History
2022-02-14
5:01 pm
Sale
2021-12-31 13G AbCellera Biologics Inc.
ABCL
VIKING GLOBAL INVESTORS LP 0
0.000%
-19,283,744decrease
(Position Closed)
Filing
History
2022-02-14
5:01 pm
Purchase
2021-12-31 13G Coupa Software Incorporated
COUP
VIKING GLOBAL INVESTORS LP 4,168,030
5.600%
322,311increase
(+8.38%)
Filing
History
2022-01-21
5:05 pm
Purchase
2022-01-11 13G Amylyx Pharmaceuticals, Inc.
AMLX
VIKING GLOBAL INVESTORS LP 7,170,536
12.400%
7,170,536increase
(New Position)
Filing
History
2022-01-18
4:25 pm
Purchase
2022-01-06 13G Guardant Health, Inc.
GH
VIKING GLOBAL INVESTORS LP 5,122,495
5.000%
5,122,495increase
(New Position)
Filing
History
2022-01-05
5:29 pm
Purchase
2022-01-03 13G APi Group Corporation
APG
VIKING GLOBAL INVESTORS LP 41,463,414
17.300%
8,130,081increase
(+24.39%)
Filing
History
2021-10-15
4:05 pm
Purchase
2021-10-05 13G TDCX Inc.
TDCX
VIKING GLOBAL INVESTORS LP 1,020,408
4.600%
1,020,408increase
(New Position)
Filing
History
2021-10-01
5:02 pm
Unchanged
2021-09-27 13D Ginkgo Bioworks Holdings, Inc.
DNA
VIKING GLOBAL INVESTORS LP 7,573,574
22.800%
0
(Unchanged)
Filing
History
2021-09-27
5:21 pm
Purchase
2021-09-17 13G PROCEPT BioRobotics Corporation
PRCT
VIKING GLOBAL INVESTORS LP 4,907,892
11.300%
4,907,892increase
(New Position)
Filing
History
Goto Prev, 0, 1, ...3, 4, 5, 6, 7, Next